Drug resistance modulation in the laboratory and the clinic

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Oncogene·2015

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.

British journal of cancer·2014

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.

Leukemia·2013

Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.

Oncogene·2011

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.

Leukemia·2010

Absorption cell for the infrared spectroscopy of heated gas.

Applied optics·2010

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Seminars in oncology·2026

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Seminars in oncology·2026

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

Seminars in oncology·2026

A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategies.

Seminars in oncology·2026

Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience.

Seminars in oncology·2026

From imaging to action: MRI features direct surgical strategy in low rectal cancer.

Seminars in oncology·2026

PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway.

Journal of hepatocellular carcinoma·2026

Breaking the antimicrobial resistance dilemma: marine natural products, a treasure trove for the development of new anti-Staphylococcus aureus drugs.

Marine life science & technology·2026

Optimizing plasma-derived small extracellular vesicle purification to enhance downstream applications.

iScience·2026

Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems.

International journal of pharmaceutics: X·2026

N-Terminal polarity reversal of cysteine-terminated peptides: A strategy to develop potent metallo-β-lactamase inhibitors with in vivo efficacy.

European journal of medicinal chemistry·2026

Non-Oncology Biomarkers in Precision Medicine: A Narrative Review.

Therapeutic innovation & regulatory science·2026

Related Experiment Videos

Drug resistance modulation in the laboratory and the clinic

Related Concept Videos

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.

Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.

Absorption cell for the infrared spectroscopy of heated gas.

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategies.

Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience.

From imaging to action: MRI features direct surgical strategy in low rectal cancer.

PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway.

Breaking the antimicrobial resistance dilemma: marine natural products, a treasure trove for the development of new anti-Staphylococcus aureus drugs.

Optimizing plasma-derived small extracellular vesicle purification to enhance downstream applications.

Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems.

N-Terminal polarity reversal of cysteine-terminated peptides: A strategy to develop potent metallo-β-lactamase inhibitors with in vivo efficacy.

Non-Oncology Biomarkers in Precision Medicine: A Narrative Review.

Related Experiment Videos

Drug resistance modulation in the laboratory and the clinic

Related Concept Videos

Related Articles